Retatrutide met primary and key secondary endpoints in a 2339-participant, randomized, double-blind, placebo-controlled phase 3 trial, demonstrating clinically meaningful weight reduction across 4, 9, ...
SAO PAULO, May 19 (Reuters) - Brazil's Finance Ministry on Tuesday released a preliminary proposal for phased sectoral coverage of the country's regulated carbon market, outlining which industries ...
Two phase 3, randomized trials of inhaled treprostinil for idiopathic pulmonary fibrosis (IPF) were conducted on the basis of preclinical and clinical evidence of an antifibrotic mechanism. TETON-2 ...
When you order a new broadcast transmitter, one of the first questions will be about power. Is it single-phase or three-phase alternating current? If single-phase, it is 208 or 240 volts? If it is ...
The system integrates a battery, hybrid inverter, and home energy management system into a single device. It supports the integration of additional appliances, including heat pumps via SG-Ready ...
Takeda has posted phase 3 data on an autoimmune asset it acquired for $4 billion, laying down a marker ahead of a fight for market share with companies including Bristol Myers Squibb and Johnson & ...
It's triple joy for Mamma Mia! fans today – not only have the first two films in the series been added to Netflix in the UK, but we now have a more definitive update on a potential third film. Ever ...
Gossamer Bio plans to talk with the FDA about the path forward for seralutinib in pulmonary arterial hypertension. (iStock / Getty Images Plus) A phase 3 study of Gossamer Bio’s seralutinib in ...
Compass Pathways has announced that its investigational psilocybin treatment has successfully met its primary endpoint in a second Phase 3 clinical trial moving it one step closer to FDA submission.
Tesla has announced the Powerwall 3P, a new variant of its home battery with a native three-phase inverter built into a single unit. The product, announced for the German market first, eliminates the ...
Altimmune closed a $75M direct offering to fund Phase 3 pemvidutide trials for MASH, leveraging recent positive Phase 2b data and FDA Breakthrough Therapy status. Pemvidutide’s dual GLP-1/glucagon ...
Both dosage regimens of amlitelimab were associated with statistically significant improvements in skin clearance and disease severity vs placebo in the US estimand. Topline data were announced from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results